Bulletin No. 1, 2023

“Innovative Biomedicine” is one of the strategic areas outlined in the Strategic Plan . With the inception of InnoHK and the government’s plan to set up an InnoLife Healthtech Hub at the Lok Ma Chau Loop Hong Kong-Shenzhen Innovation and Technology Park, the development path of translational biomedicine has never been more promising. CUHK will tap into these opportunities and resources to build on its successes to make an important contribution to the innovation agenda. The grand challenges facing the world require global collaboration. Strategic engagement with mainland China and the world will continue to be the University’s priority. As a comprehensive research university, CUHK is committed to fostering interdisciplinary research with its international counterparts to facilitate holistic human health. This issue of CU Bulletin takes the University’s three health-focused InnoHK Centres to tell that story. a vital part of its mission. “We focus on integrating research, innovation and enterprise into a dynamic and productive continuum, a superhighway that enables the translation of research into tangible benefits and the delivery of innovation to the world,” says Professor Sham. As co-chairperson of the Sub-group on Research and Innovation for the CUHK Strategic Plan 2021–25 , Professor Sham was a major part of driving the University’s new conceptual roadmap approach to the innovation agenda. Under this approach, CUHK sees the integration of research, innovation and enterprise forming a dynamic and productive continuum delivering tangible benefits to society. Under the theme of “excellence with purpose and responsibility”, the Strategic Plan reflects the University’s determination to create and nourish an ecosystem that is conducive to the flourishing of knowledge creation, technology transfer and global community. A dynamic and productive continuum delivering societal benefits Envisioning a healthier future 9 The brave new world of biomedicine